Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 21;20(17):4076.
doi: 10.3390/ijms20174076.

Plakophilin-2 Haploinsufficiency Causes Calcium Handling Deficits and Modulates the Cardiac Response Towards Stress

Affiliations

Plakophilin-2 Haploinsufficiency Causes Calcium Handling Deficits and Modulates the Cardiac Response Towards Stress

Chantal J M van Opbergen et al. Int J Mol Sci. .

Abstract

Human variants in plakophilin-2 (PKP2) associate with most cases of familial arrhythmogenic cardiomyopathy (ACM). Recent studies show that PKP2 not only maintains intercellular coupling, but also regulates transcription of genes involved in Ca2+ cycling and cardiac rhythm. ACM penetrance is low and it remains uncertain, which genetic and environmental modifiers are crucial for developing the cardiomyopathy. In this study, heterozygous PKP2 knock-out mice (PKP2-Hz) were used to investigate the influence of exercise, pressure overload, and inflammation on a PKP2-related disease progression. In PKP2-Hz mice, protein levels of Ca2+-handling proteins were reduced compared to wildtype (WT). PKP2-Hz hearts exposed to voluntary exercise training showed right ventricular lateral connexin43 expression, right ventricular conduction slowing, and a higher susceptibility towards arrhythmias. Pressure overload increased levels of fibrosis in PKP2-Hz hearts, without affecting the susceptibility towards arrhythmias. Experimental autoimmune myocarditis caused more severe subepicardial fibrosis, cell death, and inflammatory infiltrates in PKP2-Hz hearts than in WT. To conclude, PKP2 haploinsufficiency in the murine heart modulates the cardiac response to environmental modifiers via different mechanisms. Exercise upon PKP2 deficiency induces a pro-arrhythmic cardiac remodeling, likely based on impaired Ca2+ cycling and electrical conduction, versus structural remodeling. Pathophysiological stimuli mainly exaggerate the fibrotic and inflammatory response.

Keywords: arrhythmogenic cardiomyopathy; calcium handling; cardiac pressure overload; exercise; fibrosis; inflammation; plakophilin-2; second hit.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Remodeling of proteins involved in calcium signaling pathways in the PKP2-Hz mouse. Representative western blots (left) and average densitometry (right; n = 5 for all groups) of ankyrinB (AnkB), calsequestrin-2 (Casq2), Cav1.2, and SERCA2a, measured from wildtype and PKP2-Hz ventricular lysates of three-month-old mice. Left upper panels represent western blots, bottom panels according to ponceau staining used for quantification (mean ± SEM, * p < 0.05).
Figure 2
Figure 2
Absence of cardiac remodeling in three and six months old PKP2-Hz mice. (A) Hematoxylin and eosin staining of wildtype and PKP2-Hz heart sections, at three and six months of age; scale bar, 100 µm. (B) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium of wildtype and PKP2-Hz murine hearts of both ages; scale bar, 500 µm. Quantification of collagen abundance (right panel) in overview slides of whole heart sections (WT 3 months; n = 7, PKP2-Hz three months; n = 7, WT six months; n = 6, PKP2-Hz six months; n = 6, mean ± SEM). (C) Relative mRNA expression of Col1α1, Col1α2, MM9, Timp1, NF-κß, and IL-6 assessed by RT-qPCR in three (left) and six month old (right), wildtype and PKP2-Hz ventricular tissue (three months; n = 6 for all groups, six months; n = 4 for all groups, mean ± SEM, * p < 0.05). (D) Quantification of heart weight (HW) to body weight (BW) ratio (WT three months; n = 8, PKP2-Hz three months; n = 8, WT six months; n = 10, PKP2-Hz six months; n = 10, mean ± SEM, * p < 0.05). (E) Percentage of Langendorf-perfused hearts within each group susceptible for sustained ventricular arrhythmias by epicardial pacing (WT three months; n = 8, PKP2-Hz three months; n = 8, WT six months; n = 10, PKP2-Hz six months; n = 10). (F) Representative western blots (bottom) and average densitometry of N-cadherin (Ncad), connexin 43 (Cx43), and plakoglobin (PKG; top, WT; n = 6, PKP2-Hz n = 5 for Cx43 and PKG, WT; n = 4, PKP2-Hz n = 5 for Ncad), measured from wildtype and PKP2-Hz ventricular lysates, six months of age. Upper panels represent western blots, bottom panels according ponceau staining used for quantification (mean ± SEM, * p < 0.05). (G) Immunofluorescence staining for Cx43 (green) and Ncad (red) in wildtype (WT) and PKP2-Hz (PKP2) heart sections of three (3M) and six months (6M) of age; Scale bar, 100 µm.
Figure 3
Figure 3
Pro-arrhythmic cardiac remodeling in PKP2-Hz mice exposed to exercise training. (A) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium of wildtype and PKP2-Hz murine heart sections, of mice exposed to exercise training; scale bar, 500 µm. Quantification of collagen abundance (right panel) in overview slides of whole heart sections (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM). (B) Hematoxylin and eosin staining of wildtype and PKP2-Hz heart sections, of mice exposed to exercise; scale bar, 100 µm. (C) Quantification of heart weight (HW) to body weight (BW) ratio in both groups (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM). (D) Representative western blots (left panel) and average densitometry (right panels, n = 5 for all groups) of AnkyrinB (ANKB), Cav1.2, and calsequestrin-2 (Casq2) measured from wildtype (WT) and PKP2-Hz ventricular lysates of mice exposed to exercise training. Left upper panels represent western blots, bottom panels according ponceau staining used for quantification (mean ± SEM, * p < 0.05). (E) Immunofluorescence staining for Cx43 (red) and Ncad (green) in right ventricular heart sections of WT and PKP2-Hz mice; scale bar, 100 µm. Upper right panel shows magnified shots of according merged pictures, indicated by the white boxes. Lateral Cx43 expression is more pronounced in PKP2-Hz hearts exposed to exercise training, indicated by white arrows. (F) Left ventricular fractional shortening examined via echocardiography in hearts of wildtype (WT) and PKP2-Hz mice after one-month of training (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM). (G) Conduction (CV) velocity measured by epicardial mapping on the left ventricle (LV) and right ventricle (RV) in longitudinal (left) and transverse (right) directions in hearts of wildtype (WT) and PKP2-Hz mice (WT; n = 5 and PKP2-Hz; n = 5, mean ± SEM, * p < 0.05). (H) Percentage of Langendorf-perfused hearts, within each group, susceptible for sustained ventricular arrhythmias by epicardial pacing (WT; n = 5 and PKP2-Hz; n = 5).
Figure 4
Figure 4
Pro-fibrotic cardiac remodeling in PKP2-Hz trans aortic constriction (TAC) operated mice. (A) Hematoxylin and eosin staining of wildtype and PKP2-Hz heart sections of Sham and TAC operated mice; scale bar, 100 µm. (B) Quantification of heart weight (HW) to body weight (BW) ratio in all four groups (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, ** p < 0.01). (C) Left ventricular fractional shortening examined by echocardiography in wildtype (WT) and PKP2-Hz mice after eight weeks of TAC/Sham surgery (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001). (D) QRS duration (left) and ventricular repolarization (QT) time corrected for heart rate (QTc; right) examined via electrocardiograms in wildtype (WT) and PKP2-Hz mice after eight weeks of surgery (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, *** p < 0.001). (E) Percentage of Langendorf-perfused hearts, within each group, susceptible for sustained ventricular arrhythmias by epicardial pacing (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9). (F) Immunofluorescence staining for Cx43 (green) and Ncad (red) in wildtype and PKP2-Hz (PKP2) heart sections of mice exposed to Sham (SH) or TAC surgery; scale bar, 100 µm. (G) Representative pictures of Picrosirius red staining (left panel) in the inner myocardium of all four groups; scale bar, 500 µm. Quantification of collagen abundance (right panel) in overview slides of whole heart sections (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM, * p < 0.05). (H) Quantification of collagen abundance (right panel) in the 0.2 mm subepicardial layer, examined in overview slides of whole heart sections (WT Sham; n = 5, PKP2-Hz sham; n = 8, WT TAC; n = 8, and PKP2-Hz TAC; n = 9, mean ± SEM).
Figure 5
Figure 5
Exaggerated cardiac fibrotic and inflammatory response in PKP2-Hz mice exposed to autoimmune myocarditis. (A) Representative pictures of Picrosirius red staining (left panel) of the outer myocardial layer in wildtype and PKP2-Hz murine heart sections, of mice after three weeks of experimental auto-immune myocarditis (3wk EAM) and six weeks of experimental auto-immune myocarditis onset (6wk EAM; scale bar, 750 µm). (B) Quantification of collagen abundance in the entire heart (left panel) and 0.2 mm subepicardial region (right panel) of wildtype (WT) and PKP2-Hz (PKP2) mice after three weeks experimental autoimmune myocarditis (EAM) and six weeks EAM onset or without treatment (untreated; WT 3wk EAM; n = 9, PKP2 3wk EAM, n = 11, WT 6wk EAM; n = 16, PKP2 3wk EAM, n = 15, WT untreated; n = 5, and PKP2 untreated, n = 4, mean ± SEM, * p < 0.05). (C) Hematoxylin and eosin (H&E) staining in wildtype and PKP2-Hz heart sections exposed to EAM; scale bar, 500 µm. (D) Quantification of damaged area in the 0.2 mm subepicardial layer of wildtype (WT) and PKP2-Hz (PKP2) mice hearts exposed to EAM or without any treatment, quantification was performed on H&E stained heart sections (WT 3wk EAM; n = 9, PKP2 3wk EAM, n = 11, WT 6wk EAM; n = 16, PKP2 6wk EAM, n = 15, WT untreated; n = 5, and PKP2 untreated, n = 4, mean ± SEM, * p < 0.05, *** p < 0.001). (E) Representative examples of Connexin 43 (Cx43) immunohistochemistry labeling in the subepicardial region of WT and PKP2-Hz heart sections exposed to EAM; scale bar, 100 µm. (F) Representative examples (right) of myosin (red) and vimentin (green) immunofluorescence labeling and quantification of non-myosin area (left) in wildtype and PKP2-Hz heart sections of mice exposed to EAM; scale bar, 100 µm. The non-myosin area was examined in the epicardial layer of both ventricles, areas were normalized by the length of the epicardium (WT 3wk EAM; n = 8, PKP2 3wk EAM, n = 11, WT 6wk EAM; n = 16, and PKP2 6wk EAM, n = 15, mean ± SEM, * p < 0.05, ** p < 0.01). (G) Quantification of Ly6C/6G (neutrophil) coverage area (left) in whole heart and 0.2 mm subepicardial regions of wildtype and PKP2-Hz mice after three weeks EAM onset (WT whole heart; n = 8, PKP2 whole heart, n = 11, WT subepicard; n = 9, and PKP2 subepicard, n = 11, mean ± SEM, * p < 0.05). Representative example (right) of the neutrophil positive area in both groups; scale bar, 500 µm.

References

    1. Müssigbrodt A., Knopp H., Czimbalmos C., Jahnke C., Richter S., Husser D., Gradistanac T., Hindricks G. Exercise-related sudden cardiac death of an American football player with arrhythmogenic right ventricular dysplasia/cardiomyopathy AND sarcoidosis. Clin. Case Rep. 2019;7:686–688. doi: 10.1002/ccr3.2071. - DOI - PMC - PubMed
    1. Lin Y., Huang J., He S., Feng R., Zhong Z., Liu Y., Ye W., Li X., Liao H., Fei H., et al. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation. Bmc Med. Genet. 2018;19:148. doi: 10.1186/s12881-018-0580-2. - DOI - PMC - PubMed
    1. Cadrin-Tourigny J., Bosman L.P., Nozza A., Wang W., Tadros R., Bhonsale A., Bourfiss M., Fortier A., Lie H., Saguner A.M., et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2019;40:1850–1858. doi: 10.1093/eurheartj/ehz103. - DOI - PMC - PubMed
    1. Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. J. Arrhythmia. 2016;32:398–403. doi: 10.1016/j.joa.2016.01.006. - DOI - PMC - PubMed
    1. Austin K.M., Trembley M.A., Chandler S.F., Sanders S.P., Saffitz J.E., Abrams D.J., Pu W.T. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat. Rev. Cardiol. 2019;16:519–537. - PMC - PubMed

MeSH terms